Nuclear Medicine and Biology
Volume 35, Issue 8 , Pages 839-849 , November 2008

Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides

  • Wouter A.P. Breeman

      Affiliations

    • Department of Nuclear Medicine, Erasmus MC Rotterdam's 3015 CE Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 10 7035317.
    • ,
  • A.C. Fröberg

      Affiliations

    • Department of Nuclear Medicine, Erasmus MC Rotterdam's 3015 CE Rotterdam, The Netherlands
    • ,
  • E. de Blois

      Affiliations

    • Department of Nuclear Medicine, Erasmus MC Rotterdam's 3015 CE Rotterdam, The Netherlands
    • ,
  • A. van Gameren

      Affiliations

    • Department of Nuclear Medicine, Erasmus MC Rotterdam's 3015 CE Rotterdam, The Netherlands
    • ,
  • M. Melis

      Affiliations

    • Department of Nuclear Medicine, Erasmus MC Rotterdam's 3015 CE Rotterdam, The Netherlands
    • ,
  • M. de Jong

      Affiliations

    • Department of Nuclear Medicine, Erasmus MC Rotterdam's 3015 CE Rotterdam, The Netherlands
    • ,
  • T. Maina

      Affiliations

    • Molecular Radiopharmacy Section, I/R-RP, NCSR “Demokritos”, Athens, Greece
    • ,
  • B.A. Nock

      Affiliations

    • Molecular Radiopharmacy Section, I/R-RP, NCSR “Demokritos”, Athens, Greece
    • ,
  • J.L. Erion

      Affiliations

    • BioSynthema Inc., St. Louis, MO, USA
    • ,
  • H.R. Mäcke

      Affiliations

    • Radiological Chemistry, University Hospital Basel, Switzerland
    • ,
  • E.P. Krenning

      Affiliations

    • Department of Nuclear Medicine, Erasmus MC Rotterdam's 3015 CE Rotterdam, The Netherlands
    • Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands

Received 15 August 2008 ,Revised 19 September 2008 ,Accepted 28 September 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(08)00199-6

doi: 10.1016/j.nucmedbio.2008.09.006

Nuclear Medicine and Biology
Volume 35, Issue 8 , Pages 839-849 , November 2008

Article Tools

* Image Usage & Resolution